Drug Advertising, Continuing Medical Education, and Physician Prescribing: A Historical Review and Reform Proposal

Journal of Law, Medicine and Ethics 38 (4):807-815 (2010)
  Copy   BIBTEX

Abstract

Public policy tries to promote appropriate drug use by allowing firms to market drugs in interstate commerce only for uses that the Food and Drug Administration has found to be safe and effective. Because of their medical knowledge, physicians are authorized to prescribe drugs even for uses unapproved by the FDA. Nevertheless, physicians have relied on drug firms for information on appropriate prescribing despite the inherent tension between drug firm dissemination of information to promote sales and rational prescribing. In the past, physicians often relied particularly on drug firm advertising for information on drug use. Today, physicians rely on drug firms to finance continuing medical education. A historical review reveals connections between these two different ways commercial interests have influenced the information that physicians receive and points the way to needed reforms.

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 98,098

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Prescription Data Mining and the Protection of Patients' Interests.David Orentlicher - 2010 - Journal of Law, Medicine and Ethics 38 (1):74-84.
Praxis Makes Perfect?Joseph J. Fins - 1993 - Hastings Center Report 23 (5):16-19.

Analytics

Added to PP
2010-11-25

Downloads
23 (#800,199)

6 months
4 (#1,170,730)

Historical graph of downloads
How can I increase my downloads?